Search for: "In Re Omeprazole Patent Litigation"
Results 1 - 20
of 45
Sort by Relevance
|
Sort by Date
7 Apr 2015, 11:49 am
In re Omeprazole Patent Litig., 536F.3d 1361 (Fed. [read post]
7 Apr 2015, 10:24 am
Cir. 2007) (“Omeprazole II”); In re Omeprazole Patent Litig., 281 F. [read post]
23 Jan 2013, 12:32 pm
This court explained in In re Omeprazole Patent Litigation, 483 F.3d 1364 (Fed. [read post]
20 Nov 2012, 7:50 am
These, readers may recall, are the actions which challenge the legality of legislating unitary patent law for just 25 of the 27 EU Member States. [read post]
13 Jul 2011, 10:47 am
Last week the District Court of The Hague gave judgment in Stada and Sandoz v AstraZeneca, a big pharma patent case concerning esomeprazole The patent at issue, EP 1 020 461, relates to the S-enantiomer of the well-known blockbuster gastric acid secretion inhibitor omeprazole, in a specific purity grade (> 99.8 enantiomeric excess). [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds… [read post]
24 Sep 2010, 1:15 pm
Examples + Teaching Points In re Omeprazole Patent Litigation, 536 F.3d 1361 (Fed. [read post]
2 Sep 2010, 5:56 pm
[In re Omeprazole Patent Litigation, 536 F.3d 1361 (Fed. [read post]
2 Sep 2010, 10:51 am
Combining Prior Art Elements In re Omeprazole Patent Litigation, 536 F.3d 1361 (Fed. [read post]
3 Jun 2010, 5:35 am
(Spicy IP) Wellbutrin (Bupropion) – US: Pennsylvania District Court decision signals a new turn in the generic drug preemption debate; a tough pill to swallow for the generic industry: In re Budeprion XL Marketing & Sales Litigation (FDA Law Blog) [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
6 Apr 2009, 4:27 pm
See In re Omeprazole Patent Litig., 536 F.3d 1361, 1373-75 (Fed. [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs)… [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent… [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In… [read post]
31 Oct 2008, 6:05 pm
Cir. 2008) (citing In re Omeprazole Patent Litig., 483 F.3d 1364, 1379 (Fed. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol… [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi… [read post]
6 Oct 2008, 7:23 am
Cir. 2008) (citing In re Omeprazole Patent Litig., 483 F.3d 1364, 1379 (Fed. [read post]
9 Sep 2008, 1:28 am
In re Omeprazole Patent Litigation (Astrazeneca v. [read post]
